Cancer Super-Survivors May Hold Keys to New Treatments
Researchers typically ask why people get cancer. What if they studied why some survive — or never develop the disease?
Read more...Researchers typically ask why people get cancer. What if they studied why some survive — or never develop the disease?
Read more...Eco-taxes to reduce fuel emissions not only lower CO2 levels, but also reduce pollution, helping poor neighborhoods the most.
Read more...Part the First: Is This How to Do Science? San Diego, with the University of California-San Diego and the Scripps Research Institute leading the way, has been a Biotech/Little Pharma hotspot since the beginning, a strong third behind Boston and the Bay Area. Ups and downs are common, but in the current climate it is […]
Read more...If Trump does not blink on his tariff threat against India over Russia oil buys, could his program kick of deflationary pressures?
Read more...Heat risks are rising along with global temperatures. Some warning signs in vulnerable groups, including those who take certain medications
Read more...Part the First: How Do You Awaken Sleeping Cancer Cells. Short answer: Inflammation. Speaking from experience, anyone who have ever been treated successfully for cancer never fully relaxes after his or her tumor or condition is resolved. Formerly metastatic cells can remain dormant for a long time. Recent research has shown how they are reawakened. […]
Read more...RFK, Jr.’s policy views confirm that he hates the poors.
Read more...A theory of what might cause the many symptoms of Long Covid, which if proven further, should help in developing treatments
Read more...Trump has sent a wrecking ball through US healthcare. Can states team up to preserve some measure of the old normal?
Read more...In the United States, the aim of the Current Administration is to support something called “gold-standard science.” Their clear implication is that American scientists have been publishing something less than the gold standard – perhaps silver or bronze, or maybe even brass, when gold is the standard of the day (here and here). We have […]
Read more...The rise of private-equity-owned plastic surgery mills has produce patient litigatation, often with damning details.
Read more...Part the First: Pharmacopeia. Who doesn’t love a garden? It sometimes seems that all drugs come from plants, initially. My first biology teachers claimed they were taught that bacteria were plants back when life was either animal or plant. Garden of Healing is a bit long but very interesting. It is also a break from […]
Read more...Part the First: Algorithmic Intelligence in Clinical Medicine. From the article This Ohio health system tested an AI tool to predict sepsis. Here’s how it went. As the subhead notes: Summa Health’s experience highlights the challenges of AI adoption, especially at community health systems: Across emergency departments around Akron, Ohio, physicians were getting overwhelmed. In […]
Read more...The Gates Foundation steps into the void left by the U.S., and brings with it limited accountability, conflicts of interest, and a history of failure in its stated mission.
Read more...On this Independence Day in one country in North America a few notes on life outside current politics, scientific and otherwise. Part the First: The Archaeology of Food Is Fascinating. Having read about Roman eating habits over the years I have wondered about two things, fish sauce and the dormouse. Now we know which fish […]
Read more...